4//SEC Filing
Mengler Christopher 4
Accession 0001209191-10-052780
CIK 0001003642other
Filed
Nov 2, 8:00 PM ET
Accepted
Nov 3, 10:24 AM ET
Size
7.4 KB
Accession
0001209191-10-052780
Insider Transaction Report
Form 4
Mengler Christopher
President, Global Pharm. Div.
Transactions
- Sale
Common Stock
2010-10-22$21.26/sh−2,000$42,520→ 29,666 total - Sale
Common Stock
2010-10-25$21.24/sh−40,956$869,905→ 7,460 total
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price reflecting the following individual transactions: 100 shares at $21.2716; 700 shares at $21.27; and 1,200 shares at $21.26.
- [F2]This total reflects the effect of other transactions that have occurred since the date of the reporting person's last Form 4.
- [F3]The price reported in Column 4 is a weighted average price reflecting the following individual transactions: 5,000 shares at $21.4424; 2,000 shares at $21.4265; 5,000 shares at $21.3731; 5,000 shares at $21.3479; 2,084 shares at $21.28; 16,666 shares at $21.1487; and 5,206 shares at $21.0266.
Documents
Issuer
IMPAX LABORATORIES INC
CIK 0001003642
Entity typeother
Related Parties
1- filerCIK 0001336015
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 8:00 PM ET
- Accepted
- Nov 3, 10:24 AM ET
- Size
- 7.4 KB